SI himself said there are 7 million patients(only in US and EU) suffering with back pain.
Going extremely conservative, 500k(out of 7 million) patients taking up MSB cells as treatment paying $20,000 each.
Again taking taking a conservative margin of 50%, gives us 10,000USD per patient. profit of 5 Billion USD per annum.
with conservative PE of 20, it gets us $100Billion USD as MCap.
around $140AUD SP.
This is only from CLBP.
Add or take away as you wish.
Where do you see the value of MESO once CLBP approved in 2026?
We need more diamond hands.
P.S: this is the simplest(big picture) and yet conservative valuation of the company few years after CLBP approval.
Please feel free to add/correct where my analysis is wrong.
SI himself said there are 7 million patients(only in US and EU)...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.020(1.87%) |
Mkt cap ! $1.244B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.11 | $1.07 | $4.338M | 3.980M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 13222 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 61499 | 3 |
View Market Depth
| Last trade - 16.10pm 13/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.09 |
Change
0.020 ( 1.42 %) |
||||
| Open | High | Low | Volume | ||
| $1.08 | $1.11 | $1.07 | 875231 | ||
| Last updated 15.59pm 13/06/2024 ? | |||||
| MSB (ASX) Chart |